Oireachtas Joint and Select Committees
Wednesday, 30 January 2019
Joint Oireachtas Committee on Health
Implications for Health Sector of United Kingdom's Withdrawal from the EU: Discussion (Resumed)
Michael Harty (Clare, Independent) | Oireachtas source
I ask Ms Nolan about medicines. Will HPRA recognition and approval of drugs process change after Brexit? I presume existing drugs will be recognised. As new drugs come from the United Kingdom, however, will there be a different process of recognition and approval?
No comments